Print version ISSN 0004-282X
Arq. Neuro-Psiquiatr. vol.70 no.8 São Paulo Aug. 2012
Frequência e manifestações clínicas da síndrome pós-poliomielite em um centro terciário brasileiro
Abrahão Augusto Juviniano QuadrosI; Mônica Tilli Reis Pessoa CondeII; Luis Fabiano MarinIII; Helga Cristina Almeida SilvaIII; Tatiana Mesquita e SilvaIII; Maria Bernadete Eduardo de PaulaIV; Roberto Dias Batista PereiraIII; Paulo Eduardo RamosIII; Gislane AbeIII; Acary Souza Bulle OliveiraIII
IDepartment of Neurology and Neurosurgery, Division of Neuromuscular Disorders, Federal University of São Paulo (Unifesp); Neurologic Rehabilitation Service of the Policlínica at Centro Universitário Adventista de São Paulo (Unasp), São Paulo SP, Brazil
IICenter for Disease Control and Prevention of the Municipal Secretary Office of Health, São Paulo SP, Brazil
IIIDepartment of Neurology and Neurosurgery, Division of Neuromuscular Disorders, Federal University of São Paulo (Unifesp), São Paulo SP, Brazil
IVCenter for Vigilance Epidemiology of the State Secretary Office of Health, São Paulo SP, Brazil
OBJECTIVE: To determine the frequency and clinical manifestations of patients with post-poliomyelitis syndrome (PPS) in a Brazilian division of neuromuscular disorders.
METHODS: A total of 167 patients with prior history of paralytic poliomyelitis was investigated for PPS, based on international diagnostic criteria. Other variables analyzed were: gender, race, age at poliomyelitis infection, age at PPS onset, and PPS symptoms.
RESULTS: One hundred and twenty-nine patients presented PPS, corresponding to 77.2% of the studied population. 62.8% were women and 37.2% were men. Mean age of patients with PPS at onset of PPS symptoms was 39.9±9.69 years. Their main clinical manifestations were: new weakness in the previously affected limbs (69%) and in the apparently not affected limbs (31%); joint pain (79.8%); fatigue (77.5%); muscle pain (76%); and cold intolerance (69.8%).
CONCLUSIONS: Most patients of our sample presented PPS. In Brazil, PPS frequency and clinical features are quite similar to those of other countries.
Key words: post-polio syndrome, poliomyelitis, prevalence.
OBJETIVO: Determinar a frequência e as manifestações clínicas de pacientes com síndrome pós-poliomielite (SPP) em um setor terciário de doenças neuromusculares brasileiro.
MÉTODOS: Um total de 167 pacientes com história prévia de poliomielite paralítica foi estudado para diagnóstico de SPP, de acordo com critérios diagnósticos internacionais. Além da SPP, as variáveis analisadas foram: gênero, raça, idade à época da poliomielite aguda e idade no início dos sintomas da SPP.
RESULTADOS: Cento e vinte e nove pacientes apresentaram SPP, correspondendo a 77,2% da população estudada. Mulheres constituíram 62,8% dos pacientes e os homens, 37,2%. A média de idade dos pacientes com SPP à época do início dos sintomas foi de 39,9±9,69 anos. Suas principais manifestações clínicas foram: manifestações novas de fraqueza em membros previamente afetados (69%) e em membros aparentemente não afetados (31%); dores articulares (79,8%); fadiga (77,5%); dor muscular (76%) e intolerância ao frio (69,8%).
CONCLUSÕES: A maioria dos pacientes da presente casuística apresentou SPP. No Brasil, a frequência e as características clínicas da SPP são similares às observadas em outros países.
Palavras-Chave: síndrome pós-poliomielite, poliomielite, prevalência.
Paralytic poliomyelitis is an old disease that occurred sporadically from 1600 to 1300 BC1. However, epidemic poliomyelitis is a modern disease related to improvement of sanitary conditions of the Western world2. The first epidemiological data on poliomyelitis in Brazil were known in 19103. In 1994, the World Health Organization (WHO) declared Brazil as polio-free4.
Some patients have shown a new set of symptoms decades after recovery from acute poliomyelitis, which has been called post-poliomyelitis syndrome (PPS). This is a neurological disorder characterized by a cluster of symptoms, such as new weakness, abnormal muscle fatigability, and muscle and joint pain. Less commonly, muscle atrophy, breathing and swallowing difficulties, and cold intolerance may be present5. For a long time, the PPS was not considered a disease, and since October 2008 the WHO, in its International Classification of Diseases (ICD), recognized it as a distinct and incurable disease (ICD=G14).
In Brazil, few epidemiological studies on the frequency and on the symptoms of PPS were performed. In this scenario, our objective was to determine the frequency and the clinical manifestations of a large series of patients with PPS in a Brazilian division of neuromuscular disorders.
This study included 167 consecutive patients with prior history of poliomyelitis, who were admitted between March 2003 and June 2004 in the post-poliomyelitis outpatient sector of the Division of Neuromuscular Diseases from the Department of Neurology and Neurosurgery of the Federal University of São Paulo (Unifesp). All patients had paralytic poliomyelitis, were born and lived in Brazil. All of them were over 18 years of age.
PPS diagnosis was performed according to Halstead's criteria6. Furthermore, in our sample, we included only patients who had functional and neurological stability for at least 15 years, and the new symptoms should have persisted for more than one year7.
Exclusion factors included: patients with paralysis who had no clear history of acute infection by the poliovirus; electroneuromyography without typical features of prior infection by the poliovirus; and patients with other motor neuron diseases, such as amyotrophic lateral sclerosis or progressive spinal muscular atrophy.
Electroneuromyography was performed in all patients, and identified typical features of prior infection by the poliovirus.
The evaluation protocol consisted of a questionnaire containing the following variables: age, gender, race, age at acute infection by poliovirus, age at onset of PPS symptoms, PPS symptoms (new weakness, muscle pain, joint pain, fatigue, cold intolerance, cramps, new atrophy, fasciculation, headache, dyspnea, and dysphagia). A neurological examination was performed by neurologists experienced in neuromuscular diseases. Fatigue was considered in those who met the score in the Fatigue Severity Scale (FSS).
From the 167 patients included in the study, 129 (77.2%) were classified as bearing PPS, of which 81 (62.8%) were women and 48 (37.2%) were men. Mean age of post-polio patients at the time of data collection was 47.3±10.07 years. Their average age at acute poliomyelitis infection was 1.11±2.57 years, and at PPS onset was 39.9±9.69 years. Their average time between polio and onset of post-polio symptoms was 37.0±10.75 years. Ninety percent of patients with PPS had not been previously vaccinated (Table 1).
The main clinical manifestations of PPS patients were: new weakness (n=129, 100%); joint pain (n=103, 79.8%); fatigue (n=100, 77.5%); muscle pain (n=98, 76.0%); cold intolerance (n=90, 69.8%); cramps (n=86, 66.7%); fasciculations (n=68, 52.7%); new atrophy (n=63, 48.8%); headache (n=62, 48.1%); dyspnea (n=53, 41.1%); and dysphagia (n=27, 20.9%), as seen in Table 2.
New muscle weakness occurred in the limb with motor sequelae in 69% of patients, while 31% of them developed weakness in unaffected limbs.
In Brazil, there are few studies on epidemiological features of PPS. It was first reported by Oliveira and Maynard, who saw PPS symptoms in 68% of patients with prior history of poliomyelitis8. Moreover, Conde et al. evaluated medical records of 132 Brazilian patients with PPS and described predictor factors of its severity9.
PPS prevalence depends on the clinical diagnostic criteria applied and on population studied, ranging from 20 to 80%7,10. In our sample, we found a PPS frequency of 77.2%, which is consistent with studies conducted in other countries. A weakness of our study might be the fact that most patients lived in the state of São Paulo, and the data may not properly represent the entire Brazilian population.
While many patients in our study had recent complaints of decline in muscle strength, the detailed clinical interview revealed that it occurred after a prolonged period of clinical stability, ranging from 15 to 69 years (average time between the polio and onset of post-polio symptoms was 37±10.75 years). In literature, Halstead and Rossi11 found an average time of functional stability of 25 years and an average time between the polio and the onset of PPS of 33 years. Dalakas et al.12 found a plateau of stability ranging from 15 to 54 years (clinical stability interval=28.8 years).
Regarding PPS symptoms, the most frequent in our sample were new weakness (100%) followed by joint pain (79.8%), fatigue (77.5%), and muscle pain (76%), which are also the most common symptoms reported in different studies7,9,11-14.
In conclusion, our series of post-polio patients report frequency and clinical manifestations similar to other series of non-Brazilian populations and contribute to better understanding regional characteristics of the illness.
1. Shepherd G, Simsolo V, Verones IR. Enteroviroses: I - Poliomielite. In: Veronesi R, et al. (eds). Doenças Infecciosas e Parasitárias. Rio de Janeiro: Guanabara Koogan; 1976, p. 104-124. [ Links ]
2. Nathanson N, Martin Jr. The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity and disappearance. Am J Epidemiol 1979;110:672-692. [ Links ]
3. Campos VLA, Nacimento RD, Maranhão E. The history of polio in Brazil and its control through immunization. Hist Cienc Saúde-Manguinhos 2003;10(Suppl 2):S1-S24. [ Links ]
4. Raymond M (clinical presentation with discussion by CHARCOT JM). Paralysie essentiele de la enfance. Atrophic musculaire consecutive. Gax Med (Paris) 1875;4:225-226. [ Links ]
5. Trojan DA, Cashman NR. Pathophysiology and diagnosis of post-polio syndrome. NeuroRehabilitation 1997;8:83-92. [ Links ]
6. Halstead LS. Post-polio syndrome: definition of an elusive concept. In: Munsat TL (ed). Post-polio syndrome. Boston, MA: Butterworth-Heinemann; 1991, p. 23-28. [ Links ]
7. Rowland LP, Bach JR, Borg K, et al. March of Dimes International Conference on Post Polio-Syndrome identifying best practices in diagnosis & cure. White Plains, NY: March of Dime; 2001, 24 p. [ Links ]
8. Oliveira ABS, Maynard FM. Síndrome pós-poliomielite: aspectos neurológicos. Rev Neurocienc 2002;10:31-34. [ Links ]
9. Conde MTRP, Oliveira AS, Quadros AAJ, et al. Post-polio syndrome: epidemiologic and prognostic aspects in Brazil. Acta Neurol Scand 2009;120:191-197. [ Links ]
10. Howard RS. Poliomyelitis and the postpolio syndrome. BMJ 2005;330:1314-1318. [ Links ]
11. Halstead LS, Rossi CD. Post-polio syndrome: clinical experience with 132 consecutive outpatients. In: Halstead LS, Weichers DO (eds). Research and Clinical Aspects of the Late Effects of Poliomyelitis. . White Plains, NY: March of Dimes Birth Defects Foundation; 1987, p. 13-26. [ Links ]
12. Dalakas MC, Elder G, Hallett M, Ravits J, Baker M. A long term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med 1986;314:959-963. [ Links ]
13. Cosgrove JL, Alexander MA, Kitts EL, et al. Late effects of poliomyelitis. Arch Phys Med Rehab 1987;68:4-7. [ Links ]
14. Agre JC, Rodriguez AA, Sperling KB, Symptoms and clinical impressions of patients seen in a post-polio clinic. Arch Phys Med Rehab 1989;70:367-370. [ Links ]
Abrahão Augusto Juviniano Quadros
Rua Estado de Israel 899
04022-002 São Paulo SP - Brasil
Received 20 March 2012
Received in final form 04 April 2012
Accepted 11 April 2012
Conflict of interest: There is no conflict of interest to declare.